Public consultation on interim decisions to amend the Poisons Standard - JUNE ACMS INTERIM DECISIONS FOR PSILOCYBINE AND MDMA 2022

Closed 24 Nov 2022

Opened 21 Oct 2022

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Feedback updated 3 Feb 2023

We asked

Between 21 October 2022 to 24 November 2022 we sought submissions from the public on the Delegate’s interim decision with respect to the proposal to amend the Poisons Standard in relation to psilocybine and MDMA that was referred to ACMS #38 in June 2022. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

Psilocybine: Through the consultation portal we received a total of 3,442 public submissions with respect to the interim decision for psilocybine, including 1,758 with a written component. Out of the total number of submissions received for psilocybine, 2,586 were in opposition of the Delegate’s interim decision.

MDMA: We received a total of 3,403 submissions through the consultation portal with respect to the interim decision for MDMA, including 1,658 with a written component. Out of the total number of submissions received for MDMA, 2,523 were in opposition of the proposed interim decision.

We did

The Delegate considered all submissions prior to making their final decisions on these substances. The final decisions for psilocybine and MDMA were published on 3 February 2023.

Published responses

View submitted responses where consent has been given to publish the response.

Overview

Scheduling amendments referred to expert advisory committee

Please note: this is a consultation for the interim decisions relating to PSILOCYBINE and MDMA ONLY. If you wish to provide comments on the other items considered at the ACMS and ACCS meetings in June 2022, please visit the alternate consultation hub by clicking the link below:

This consultation is for interim decisions made in relation to Psilocybine and MDMA proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS).

The closing date for this consultation is close of business 24 November 2022. All submissions received by the deadline will be considered by the delegate before they make a final decision.

The interim decisions under consultation are detailed in the public notice of interim decisions of June 2022. 

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committees, decisions on the proposed amendments are anticipated to be published as final decisions on the TGA website: Scheduling delegate's final decisions  at a later date.

Audiences

  • HPRG (TGA) Staff

Interests

  • Policy Development